Forus
Forus
Accelerating medicine for the people who need it, prescribe it, and create it.
About
Forus automates the entire process from prescription to affordable medication access, enabling patients to start therapy faster. Their AI-powered platform handles prior authorizations, appeal letters, enrollment forms, pharmacy routing, and benefit verifications for all drugs, insurance, and pharmacies nationwide. Forus serves doctors and their staff by reclaiming clinical time spent on administrative tasks and providing real-time prescription tracking.
Key facts
- Website
- forus.com
- Headquarters
- New York, NY, USA
- Founded
- 2021
- Total funding
- $310M (Series C)
- Valuation
- Private
- Business model
- B2B
- Tags
- BiotechnologyPharmaceuticalsHealthTechBiotechMedTech
Funding rounds
| Date | Round | Amount | Post-money | Lead investors |
|---|---|---|---|---|
| 8 Sept 2026 | Series C | $150M | $3.0B | - |
| 12 May 2026 | Funding Round | $160M | - | - |
Tech stack
Detected on forus.com, last scanned 21 Sept 2026. Run your own scan
- Compliance
- SOC 2, HIPAA
- Frontend
- Next.js, Tailwind CSS
- Analytics
- Google Analytics 4, Google Tag Manager
- CDN
- Vercel
- Email provider
- Google Workspace
Add first review
Frequently asked
How much funding has Forus raised?
Forus has raised a total of $310M in funding. The most recent round on record is Series C.